1 |
He S, Chandler M, Varani AM, Hickman AB, Dekker JP, Dyda F. 2016. Mechanisms of evolution in high-consequence drug resistance plasmids. MBio 7: e01987-16.
|
2 |
Ryoo NH, Kim EC, Hong SG, Park YJ, Lee K, Bae IK, et al. 2005. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J. Antimicrob. Chemother. 56: 698-702.
DOI
|
3 |
Yamane K, Wachino J, Suzuki S, Arakawa Y. 2008. Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob. Agents Chemother. 52: 1564-1566.
DOI
|
4 |
Landman D, Bratu S, Quale J. 2009. Contribution of ompK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae. J. Med. Microbial. 58: 1303-1308.
DOI
|
5 |
Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, et al. 2006. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol. Microbiol. 60: 1136-1151.
DOI
|
6 |
Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. 2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J. Clin. Microbiol. 43: 4178-182.
DOI
|
7 |
Jeong SH, Lee KM, Lee J, Bae IK, Kim JS, Kim HS, et al. 2015. Clonal and horizontal spread of the blaOXA-232 gene among Enterobacteriaceae in a Korean hospital. Diagn. Microbiol. Infect. Dis. 82: 70-72.
DOI
|
8 |
Naas T, Cuzon G, Truong HV, Nordmann P. 2012. Role of ISKpn7 and deletions in blaKPC gene expression. Antimicrob. Agents Chemother. 56: 4753-4759.
DOI
|
9 |
Yang Q, Fang L, Fu Y, Du X, Shen Y, Yu Y. 2015. Dissemination of NDM-1-producing Enterobacteriaceae mediated by the IncX3-type plasmid. PLoS One 10: e0129454.
DOI
|
10 |
Chen L, Chavda KD, Melano RG, Jacobs MR, Levi MH, Bonomo RA, et al. 2013. Complete sequence of a bla (KPC-2)-harboring IncFII (K1) plasmid from a Klebsiella pneumoniae sequence type 258 strain. Antimicrob. Agents. Chemother. 57: 1542-1545.
DOI
|
11 |
Kassis-Chikhani N, Frangeul L, Drieux L, Sengelin C, Jarlier V, Brisse S, et al. 2013. Complete nucleotide sequence of the first KPC-2- and SHV-12-encoding IncX plasmid, pKpS90, from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 57: 618-620.
DOI
|
12 |
Naas T, Cuzon G, Villegas MV, Lartigue MF, Quinn JP, Nordmann P. 2008. Genetic structures at the origin of acquisition of the beta-lactamase blaKPC gene. Antimicrob. Agents Chemother. 52: 1257-1263.
DOI
|
13 |
Jeong S, Kim JO, Yoon EJ, Bae IK, Lee W, Lee H, et al. 2018. Extensively drug-resistant Escherichia coli sequence type 1642 carrying an IncX3 plasmid containing the blaKPC-2 gene associated with transposon Tn4401a. Ann. Lab. Med. 38: 17-22.
DOI
|
14 |
Tseng TT, Gratwick KS, Kollman J, Park D, Nies DH, Goffeau A, et al. 1999. The RND permease superfamily: an ancient, ubiquitous, and diverse family that includes human disease and development protein. J. Mol. Microbiol. Biotechnol. 1: 107-125.
|
15 |
Pitout JD, Nordmann P, Poirel L. 2015. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob. Agents Chemother. 59: 5873-5884.
DOI
|
16 |
Nies DH. 2003. Efflux-mediated heavy metal resistance in prokaryotes. FEMS Microbiol. Rev. 27: 313-339.
DOI
|
17 |
Franke S, Grass G, Nies DH. 2001. The product of the ybdE gene of the Escherichia coli chromosome is involved in detoxification of silver ions. Microbiology 147: 965-972.
DOI
|
18 |
Franke S, Grass G, Rensing C, Nies DH. 2003. Molecular analysis of the copper-transporting efflux system CusCFBA of Escherichia coli. J. Bacteriol. 185: 3804-3812.
DOI
|
19 |
Rhomberg PR, Deshpande LM, Kirby JT, Jones RN. 2007. Activity of meropenem as serine carbapenemases evolve in US Medical Centers: monitoring report from the MYSTIC Program (2006). Diagn. Microbiol. Infect. Dis. 59: 425-432.
DOI
|
20 |
Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, et al. 2013. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect. Dis. 13: 785-796.
DOI
|
21 |
Adler A, Miller-Roll T, Assous MV, Geffen Y, Paikin S, Schwartz D, et al. 2015. A multicenter study of the clonal structure and resistance mechanism of KPC-producing Escherichia coli isolates in Israel. Clin. Microbiol. Infect. 21: 230-235.
DOI
|
22 |
Schaufler K, Semmler T, Wieler LH, Wohrmann M, Baddam R, Ahmed N, et al. 2016. Clonal spread and interspecies transmission of clinically relevant ESBL-producing Escherichia coli of ST410-another successful pandemic clone? FEMS Microbiol. Ecol. 92: fiv155.
DOI
|
23 |
Piazza A, Caltagirone M, Bitar I, Nucleo E, Spalla M, Fogato E, et al. 2016. Emergence of Escherichia coli sequence type 131 (ST131) and ST3948 with KPC-2, KPC-3 and KPC-8 carbapenemases from a long-term care and rehabilitation facility (LTCRF) in northern Italy. Adv. Exp. Med. Biol. 901: 77-89.
|
24 |
Chavda KD, Chen L, Jacobs MR, Bonomo RA, Kreiswirth BN. 2016. Molecular diversity and plasmid analysis of KPC-producing Escherichia coli. Antimicrob. Agents Chemother. 60: 4073-4081.
DOI
|
25 |
Xu G, Jiang Y, An W, Wang H, Zhang X. 2015. Emergence of KPC-2-producing Escherichia coli isolates in an urban river in Harbin, China. World J. Microbiol. Biotechnol. 31: 1443-1450.
DOI
|
26 |
Falgenhauer L, Imirzalioglu C, Ghosh H, Gwozdzinski K, Schmiedel J, Gentil K, et al. 2016. Circulation of clonal populations of fluoroquinolone-resistant CTX-M-15-producing Escherichia coli ST410 in humans and animals in Germany. Int. J. Antimicrob. Agents 47: 457-465.
DOI
|
27 |
Roer L, Overballe-Petersen S, Hansen F, Schonning K, Wang M, Roder BL, et al. 2018. Escherichia coli sequence type 410 is causing new international high-risk clones. mSphere 3: e00337-18.
|
28 |
Solgi H, Badmasti F, Aminzadeh Z, Giske CG, Pourahmad M, Vaziri F, et al. 2017. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of blaNDM-7 and blaOXA-48. Eur. J. Clin. Microbiol. Infect. Dis. 36: 2127-2135.
DOI
|
29 |
Mouloudi E, Protonotariou E, Zagorianou A, Iosifidis E, Karapanagiotou A, Giasnetsova T, et al. 2010. Bloodstream infections caused by metallo-beta-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes. Infect. Control Hosp. Epidemiol. 31: 1250-1256.
DOI
|
30 |
Ohno Y, Nakamura A, Hashimoto E, Matsutani H, Abe N, Fukuda et al. 2017. Molecular epidemiology of carbapenemase-producing Enterobacteriaceae in a primary care hospital in Japan, 2010-2013. J. Infect. Chemother. 23: 224-229.
DOI
|
31 |
Walsh TR, Weeks J, Livermore DM, Toleman MA. 2011. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect. Dis. 11: 355-362.
DOI
|
32 |
Copur Cicek A, Ozad Duzgun A, Saral A, Sandalli C. 2014. Determination of a novel integron-located variant (blaOXA-320) of Class D -lactamase in Proteus mirabilis. J. Basic Microbiol. 54:1030-1035.
DOI
|
33 |
Clinical and Laboratory Standards Institute. 2018. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Clinical and Laboratory Standards Institute, Wayne, P. A.
|
34 |
EUCAST. Antimicrobial susceptibility testing of bacteria. Available from http://www.eucast.org/ast_of_bacteria/ (Updated on Jan 2017). Accessed April 30, 2019.
|
35 |
Jeong S, Kim JO, Jeong SH, Bae IK, Song W. 2015. Evaluation of peptide nucleic acid-mediated multiplex real-time PCR kits for rapid detection of carbapenemase genes in gram-negative clinical isolates. J. Microbiol. Methods 113: 4-9.
DOI
|
36 |
Perez-Perez FJ, Hanson ND. 2002. Detection of plasmid-mediated AmpC b-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40: 2153-2162.
DOI
|